{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:56:08Z","timestamp":1794639368402,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T00:00:00Z","timestamp":1349827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00401-012-1051-z","type":"journal-article","created":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T17:19:26Z","timestamp":1349803166000},"page":"833-845","source":"Crossref","is-referenced-by-count":75,"title":["[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid \u03b2 detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies"],"prefix":"10.1007","volume":"124","author":[{"given":"Juha O.","family":"Rinne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean F.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"McLain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Kailaj\u00e4rvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor D.","family":"Grachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,10]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","volume":"64","author":"BJ Bacskai","year":"2007","unstructured":"Bacskai BJ, Frosch MP, Freeman SH et al (2007) Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 64:431\u2013434","journal-title":"Arch Neurol"},{"key":"1051_CR2","volume-title":"Theory and practice of histological techniques","year":"2007","unstructured":"Bancroft JD, Gamble M (eds) (2007) Theory and practice of histological techniques, 6th edn. Churchill Livingstone, Elselvier","edition":"6"},{"key":"1051_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351\u2013357","journal-title":"Neurobiol Aging"},{"issue":"Suppl","key":"1051_CR4","doi-asserted-by":"crossref","first-page":"P90","DOI":"10.1016\/j.jalz.2012.05.221","volume":"8","author":"C Buckley","year":"2012","unstructured":"Buckley C, Ikonomovic M, Smith A, Heurling K, Farrar G, Brooks D, Grachev I, McLain R, Sherwin P et al (2012) Flutemetamol F 18 injection PET images reflect brain beta-amyloid levels. Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc 8(Suppl):P90","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc"},{"key":"1051_CR5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jcp.22.4.410","volume":"22","author":"JH Cooper","year":"1969","unstructured":"Cooper JH (1969) An evaluation of current methods for the diagnostic histochemistry of amyloid. J Clin Pathol 22:410\u2013413","journal-title":"J Clin Pathol"},{"key":"1051_CR6","first-page":"1427","volume-title":"Robbins pathologic basis of disease","author":"RS Cotran","year":"1989","unstructured":"Cotran RS, Kumar V, Robbins SL (1989) Alzheimer\u2019s Disease. In: Kumar V, Abbas AK, Aster J, Fausto N (eds) Robbins pathologic basis of disease. WB Saunders, Philadelphia, pp 1427\u20131429"},{"key":"1051_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","volume":"68","author":"P Edison","year":"2007","unstructured":"Edison P, Archer HA, Hinz R et al (2007) Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68:501\u2013508","journal-title":"Neurology"},{"key":"1051_CR8","doi-asserted-by":"crossref","unstructured":"Edison P, Hinz R, Brooks DJ. Technical aspects of amyloid imaging for Alzheimer\u2019s disease (2011) Alzheimers Res Ther 3:25","DOI":"10.1186\/alzrt87"},{"issue":"Pt 11","key":"1051_CR9","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","volume":"129","author":"H Engler","year":"2006","unstructured":"Engler H, Forsberg A, Almkvist O et al (2006) Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease. Brain 129(Pt 11):2856\u20132866","journal-title":"Brain"},{"key":"1051_CR10","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","volume":"29","author":"A Forsberg","year":"2008","unstructured":"Forsberg A, Engler H, Almkvist O et al (2008) PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29:1456\u20131465","journal-title":"Neurobiol Aging"},{"key":"1051_CR11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.68.6.778","volume":"68","author":"J Golomb","year":"2000","unstructured":"Golomb J, Wisoff J, Miller DC et al (2000) Alzheimer\u2019s disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. J Neurol Neurosurg Psychiatry 68:778\u2013781","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1051_CR12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.22015","volume":"68","author":"R Hamilton","year":"2010","unstructured":"Hamilton R, Patel S, Lee EB et al (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68:535\u2013540","journal-title":"Ann Neurol"},{"key":"1051_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/112_2007_0701","volume":"159","author":"RS Harrison","year":"2007","unstructured":"Harrison RS, Sharpe PC, Singh Y, Fairlie DP (2007) Amyloid peptides and proteins in review. Rev Physiol Biochem Pharmacol 159:1\u201377","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"1051_CR14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005072-199710000-00002","volume":"56","author":"BT Hyman","year":"1997","unstructured":"Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095\u20131097","journal-title":"J Neuropathol Exp Neurol"},{"key":"1051_CR15","doi-asserted-by":"crossref","unstructured":"Ikonomovic M, Price J, Abrahamson E, Mathis C, Paljug W, Debnath M, Shao L, Becker C, Hamilton R, Klunk W (2012) Direct correlations of [H-3]flutemetamol binding with [H-3]PiB binding and amyloid-beta concentration and plaque load in [C-11]PiB imaged brains (S34.002). Neurology 78:S34.002","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.S34.002"},{"key":"1051_CR16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE et al (2008) Post-mortem correlates of in vivo PIB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease. Brain 131:1630\u20131645","journal-title":"Brain"},{"issue":"pt 3","key":"1051_CR17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","volume":"131","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr, Lowe VJ, Senjem ML et al (2008) 11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment. Brain 131(pt 3):665\u2013680","journal-title":"Brain"},{"key":"1051_CR18","first-page":"355","volume":"132","author":"CR Jack Jr","year":"2009","unstructured":"Jack CR Jr, Lowe VJ, Weigand SD et al (2009) Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: implications for sequence of pathological events in Alzheimer\u2019s disease. Brain 132:355\u2013365","journal-title":"Brain"},{"key":"1051_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9:119\u2013128","journal-title":"Lancet Neurol"},{"key":"1051_CR20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archneur.65.10.1281","volume":"65","author":"WE Klunk","year":"2008","unstructured":"Klunk WE (2008) Biopsy support for the validity of Pittsburgh Compound B positron emission tomography with a twist. Arch Neurol 65:1281\u20131283","journal-title":"Arch Neurol"},{"key":"1051_CR21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 55:306\u2013319","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"1051_CR22","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/brain\/awl281","volume":"129","author":"WE Klunk","year":"2006","unstructured":"Klunk WE, Mathis CA, Price JC, Lopresti BJ, DeKosky ST (2006) Two-year follow-up of amyloid deposition in patients with Alzheimer\u2019s disease. Brain 129(Pt 11):2805\u20132807","journal-title":"Brain"},{"key":"1051_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000163927","volume":"26","author":"J Koivunen","year":"2008","unstructured":"Koivunen J, Pirttila T, Kemppainen N et al (2008) PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord 26:378\u2013383","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1051_CR24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.0b013e318212015e","volume":"76","author":"J Koivunen","year":"2011","unstructured":"Koivunen J, Scheinin N, Virta JR et al (2011) Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology 76:1085\u20131090","journal-title":"Neurology"},{"key":"1051_CR25","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","volume":"65","author":"V Leinonen","year":"2008","unstructured":"Leinonen V, Alafuzoff I, Aalto S et al (2008) Assessment of \u03b2-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography by carbon-11 labelled Pittsburgh Compound B. Arch Neurol 65:1304\u20131309","journal-title":"Arch Neurol"},{"key":"1051_CR26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.22100","volume":"68","author":"V Leinonen","year":"2010","unstructured":"Leinonen V, Koivisto AM, Savolainen S et al (2010) Amyloid and tau proteins in cortical brain biopsy and Alzheimer\u2019s disease. Ann Neurol 68:446\u2013453","journal-title":"Ann Neurol"},{"key":"1051_CR27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2990.2011.01195.x","volume":"38","author":"V Leinonen","year":"2012","unstructured":"Leinonen V, Koivisto AM, Savolainen S et al (2012) Post-mortem findings in 10 patients with presumed normal pressure hydrocephalus and review of the literature. Neuropathol Appl Neurobiol 38:72\u201386","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1051_CR28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nucmedbio.2010.02.003","volume":"37","author":"KJ Lin","year":"2010","unstructured":"Lin KJ, Hsu WC, Hsiao IT et al (2010) Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent\u2014a pilot study. Nucl Med Biol 37:497\u2013508","journal-title":"Nucl Med Biol"},{"key":"1051_CR29","first-page":"1959","volume":"46","author":"B Lopresti","year":"2005","unstructured":"Lopresti B, Klunk WE, Mathis CA et al (2005) Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med 46:1959\u20131972","journal-title":"J Nucl Med"},{"key":"1051_CR30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"1051_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"1051_CR32","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2967\/jnumed.109.063305","volume":"50","author":"N Nelissen","year":"2009","unstructured":"Nelissen N, Van Laere K, Thurfjell L et al (2009) Phase 1 study of the Pittsburgh Compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer\u2019s disease. J Nucl Med 50:1251\u20131259","journal-title":"J Nucl Med"},{"key":"1051_CR33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jneumeth.2008.05.005","volume":"172","author":"CA Raji","year":"2008","unstructured":"Raji CA, Becker JT, Tsopelas ND et al (2008) Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer\u2019s disease with Pittsburgh Compound B. J Neurosci Methods 172:277\u2013282","journal-title":"J Neurosci Methods"},{"key":"1051_CR34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","volume":"9","author":"JO Rinne","year":"2010","unstructured":"Rinne JO, Brooks DJ, Rossor MN et al (2010) 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer\u2019s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol 9:363\u2013372","journal-title":"Lancet Neurol"},{"key":"1051_CR35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/WAD.0b013e3181b76415","volume":"24","author":"HC Rossetti","year":"2010","unstructured":"Rossetti HC, Munro CC, Hynan LS, Lacritz LH (2010) The CERAD neuropsychologic battery total score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord 24:138\u2013142","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1051_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"CC Rowe","year":"2008","unstructured":"Rowe CC, Ackerman U, Browne W et al (2008) Imaging of amyloid beta in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol 7:129\u2013135","journal-title":"Lancet Neurol"},{"key":"1051_CR37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe CC, Ellis KA, Rimajova M et al (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31:1275\u20131283","journal-title":"Neurobiol Aging"},{"key":"1051_CR38","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","volume":"68","author":"CC Rowe","year":"2007","unstructured":"Rowe CC, Ng S, Ackermann U et al (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68:1718\u20131725","journal-title":"Neurology"},{"key":"1051_CR39","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","volume":"78","author":"TT Sepp\u00e4l\u00e4","year":"2012","unstructured":"Sepp\u00e4l\u00e4 TT, Nerg O, Koivisto AM et al (2012) CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology. 78:1568\u20131575","journal-title":"Neurology."},{"key":"1051_CR40","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","volume":"355","author":"GW Small","year":"2006","unstructured":"Small GW, Kepe V, Ercoli LM et al (2006) PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355:2652\u20132663","journal-title":"N Engl J Med"},{"key":"1051_CR41","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1073\/pnas.87.10.3947","volume":"87","author":"MG Spillantini","year":"1990","unstructured":"Spillantini MG, Goedert M, Jakes R, Klug A (1990) Different configurational states of beta-amyloid and their distributions relative to plaques and tangles in Alzheimer disease. Proc Natl Acad Sci USA 87:3947\u20133951","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR42","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","volume":"66","author":"M Storandt","year":"2009","unstructured":"Storandt M, Mintun MA, Head D, Morris JC (2009) Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh Compound B: cognitive decline associated with Abeta deposition. Arch Neurol 66:1476\u20131481","journal-title":"Arch Neurol"},{"key":"1051_CR43","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M et al (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"1051_CR44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15:273\u2013289","journal-title":"NeuroImage"},{"key":"1051_CR45","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00308476","volume":"83","author":"PG Vallet","year":"1992","unstructured":"Vallet PG, Guntern R, Hof PR et al (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease. Acta Neuropathol 83:170\u2013178","journal-title":"Acta Neuropathol"},{"key":"1051_CR46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A et al (2010) 18Fflutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68:319\u2013329","journal-title":"Ann Neurol"},{"key":"1051_CR47","first-page":"584","volume":"12","author":"NP Verhoeff","year":"2004","unstructured":"Verhoeff NP, Wilson AA, Takeshita S et al (2004) In vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 12:584\u2013595","journal-title":"Am J Geriatr Psychiatry"},{"key":"1051_CR48","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/archneurol.2011.153","volume":"68","author":"DA Wolk","year":"2011","unstructured":"Wolk DA, Grachev ID, Buckley C et al (2011) Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Arch Neurol 68:1398\u20131403","journal-title":"Arch Neurol"},{"key":"1051_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-009-0051-4","volume":"9","author":"DA Wolk","year":"2009","unstructured":"Wolk DA, Klunk W (2009) Update on amyloid imaging: from healthy aging to Alzheimer\u2019s disease. Curr Neurol Neurosci Rep 9:345\u2013352","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1051_CR50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21598","volume":"65","author":"DA Wolk","year":"2009","unstructured":"Wolk DA, Price JC, Saxton JA et al (2009) Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol 65:557\u2013568","journal-title":"Ann Neurol"},{"key":"1051_CR51","doi-asserted-by":"crossref","unstructured":"Wolk D, Rinne J, Wong D, Leinonen V, Arnold S, Buckley C, Smith A, McLain R, Sherwin P, Farrar G, Kailajarvi M, Grachev I (2012) [18F]-Flutemetamol PET amyloid imaging and cortical biopsy histopathology in normal pressure hydrocephalus: pooled analysis of four studies (S34.001) Neurology 78:S34.001","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.S34.001"},{"key":"1051_CR52","doi-asserted-by":"crossref","unstructured":"Wong DF, Moghekar AR, Rigamonti D, Bra\u0161i\u0107 JR, Rousset O, Willis W, Buckley C, Smith A, Gok B, Sherwin P, Grachev ID (2012) An in vivo evaluation of cerebral cortical amyloid with [(18)F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients. Mole Imaging Biol Aug 10 [epub ahead of print]","DOI":"10.1007\/s11307-012-0583-x"},{"key":"1051_CR53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0070-2153(05)70008-9","volume":"70","author":"C Wu","year":"2005","unstructured":"Wu C, Pike VW, Wang Y (2005) Amyloid imaging: from benchtop to bedside. Curr Top Dev Biol 70:171\u2013213","journal-title":"Curr Top Dev Biol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-012-1051-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-012-1051-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T14:43:35Z","timestamp":1562251415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-012-1051-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,10]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1007\/s00401-012-1051-z","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,10]]}}}